Sonoma Pharmaceuticals Q2 FY27 net loss narrows 88% to $66,000
SNOA•Sonoma Pharmaceuticals’ second-quarter FY27 net loss narrowed 88% year over year to $66,000, while pretax earnings reached $382,000, its first positive quarterly result. Revenue rose 28% to $7.17 million, including a 93% increase in U.S. revenue to $2.8 million.
1. Quarterly results
Sonoma Pharmaceuticals reported a second-quarter FY27 net loss of $66,000, down 88% year over year, and pretax earnings of $382,000, its first positive quarterly result in company history. Revenue increased 28% year over year to $7.17 million, while U.S. revenue rose 93% to $2.8 million. A paid skincare co-formulation project could lead to a summer 2027 product launch if development succeeds and the partner accepts the formulation.
